Quick Answer
TANDEM DIABETES CARE INC reported Operating Income Loss of -$187.26 million for the year ending 2025.
- TANDEM DIABETES CARE INC showed a decrease of -88.9% in Operating Income Loss from 2024 to 2025.
- This data is from TANDEM DIABETES CARE INC's annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2015: -$18.70 million | Q4 2015: -$11.22 million | Q1 2016: -$19.24 million | Q2 2016: -$17.05 million | Q3 2016: -$28.41 million | Q4 2016: -$13.35 million | Q1 2017: -$21.23 million | Q2 2017: -$18.97 million | Q3 2017: -$13.17 million | Q4 2017: -$9.58 million | Q1 2018: -$15.49 million | Q2 2018: -$14.00 million | Q3 2018: -$15.71 million | Q4 2018: $560.0 thousand | Q1 2019: -$11.00 million | Q2 2019: -$1.87 million | Q3 2019: -$6.00 million | Q4 2019: $2.14 million | Q1 2020: -$13.57 million | Q2 2020: -$12.04 million | Q3 2020: -$1.01 million | Q4 2020: $18.66 million | Q1 2021: -$3.24 million | Q2 2021: $5.43 million | Q3 2021: $7.72 million | Q4 2021: $12.74 million | Q1 2022: -$15.34 million | Q2 2022: -$12.24 million | Q3 2022: -$47.49 million | Q4 2022: -$17.78 million | Q1 2023: -$127.82 million | Q2 2023: -$38.81 million | Q3 2023: -$31.55 million | Q4 2023: -$35.06 million | Q1 2024: -$41.68 million | Q2 2024: -$30.77 million | Q3 2024: -$26.09 million | Q4 2024: -$581.0 thousand | Q1 2025: -$120.88 million | Q2 2025: -$51.81 million | Q3 2025: -$22.86 million | Q4 2025: $8.29 million.
- Over the full 14 years of available data (2012 to 2025), TANDEM DIABETES CARE INC's Operating Income Loss has declined by 466.6%.
- Historical annual values: Fiscal year 2025: -$187.26 million | Fiscal year 2024: -$99.13 million | Fiscal year 2023: -$233.23 million | Fiscal year 2022: -$92.85 million | Fiscal year 2021: $22.65 million | Fiscal year 2020: -$7.96 million | Fiscal year 2019: -$16.72 million | Fiscal year 2018: -$44.63 million | Fiscal year 2017: -$62.94 million | Fiscal year 2016: -$78.05 million | Fiscal year 2015: -$69.00 million | Fiscal year 2014: -$75.66 million | Fiscal year 2013: -$49.43 million | Fiscal year 2012: -$33.05 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: